Managing Partner at Syridex Bio Joins The Wistar Institute Board

 PHILADELPHIA — (MARCH, 30, 2023) — The Wistar Institute, a global leader in biomedical research in cancer, immunology and infectious disease, is pleased to welcome Squire Servance, founder and managing partner for the Princeton, NJ-based life sciences-focused investment firm Syridex Bio, to its Board of Trustees, where he will serve on the Audit, Business Development and Scientific Advisory Committees.

Previous Post
Acclaimed Life Sciences Leaders Launch Impact Investment Firm to Accelerate Health Equity
Next Post
Syridex Bio Selected by NJEDA